Not Yet Recruiting
OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy
NCT06399172
- Conditions
- Locally Advanced Pancreatic Adenocarcinoma
- Locations
-
Not specified
Clinical trial condition
Locally Advanced Pancreatic Adenocarcinoma
Explore clinical trials studying Locally Advanced Pancreatic Adenocarcinoma. Study availability and eligibility vary by location and protocol.
37 public trials
17 recruiting studies
Locally Advanced Pancreatic Adenocarcinoma trial results
Not Yet Recruiting
Locally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy
NCT06272162
- Conditions
- Locally Advanced Pancreatic Adenocarcinoma
- Locations
-
- Catharina Hospital Eindhoven, North Brabant, Netherlands
- Amsterdam University Medical Center, VUmc Amsterdam, North Holland, Netherlands
- Radboud University Medical Center Nijmegen, Netherlands
- University Medical Center Utrecht Utrecht, Netherlands
NCT05034627
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +12 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT04669197
- Conditions
- Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Untreated Resectable Pancreatic Adenocarcinoma
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
NCT03269526
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
- Locations
-
- University of Virginia Charlottesville, Virginia, United States
NCT03077685
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- Parkview Cancer Institute Fort Wayne, Indiana, United States
- Texas Tech University Health Sciences Center El Paso, Texas, United States
- Baylor College of Medicine Houston, Texas, United States
NCT02394535
- Conditions
- Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma, +4 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- MD Anderson in Katy Houston, Texas, United States
- MD Anderson Cancer Center - League City League City, Texas, United States
- MD Anderson in Sugar Land Sugar Land, Texas, United States
Completed
Phase II/III of Randomized Controlled Clinical Research on IRE Synchronous Chemotherapy for LAPC
NCT03673137
- Conditions
- Locally Advanced Pancreatic Adenocarcinoma
- Locations
-
- Institutional Review Board of Guangzhou FUDA Cancer Hospital Guangzhou, Guangdong, China
NCT01342224
- Conditions
- Adenocarcinoma, Carcinoma, Locally Advanced Pancreatic Adenocarcinoma, +3 more
- Locations
-
- Providence Health & Services Portland, Oregon, United States
NCT01278368
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
- Locations
-
- San Raffaele Hospital Milan, Italy